Medtronic plc
MDT
Classifica tra le azioni
#184
Medtronic plc is a leading global medical technology enterprise that invents,... Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
Prezzo delle azioni
$94.59
Capitalizzazione di mercato
$120.99B
Variazione (1 giorno)
1.76%
Variazione (1 anno)
-1.39%
Paese
IE
Scambia Medtronic plc (MDT)
Categoria
Healthcare
Ricavi di Medtronic plc (MDT)
Ricavi nel Jan 2026 TTM: $35.48B
Secondo gli ultimi rapporti finanziari di Medtronic plc, i ricavi attuali dell'azienda (TTM) sono pari a $35.48B. Nel 2024, l'azienda ha registrato ricavi di $32.36B un aumento rispetto a i ricavi dell'anno 2023, che erano pari a $31.23B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Medtronic plc da 2000 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $35.48B | 5.81% |
| 2025 | $33.54B | 3.62% |
| 2024 | $32.36B | 3.64% |
| 2023 | $31.23B | -1.45% |
| 2022 | $31.69B | 5.21% |
| 2021 | $30.12B | 4.16% |
| 2020 | $28.91B | -5.38% |
| 2019 | $30.56B | 2.02% |
| 2018 | $29.95B | 0.82% |
| 2017 | $29.71B | 3.04% |
| 2016 | $28.83B | 42.31% |
| 2015 | $20.26B | 19.15% |
| 2014 | $17.01B | 2.50% |
| 2013 | $16.59B | 2.51% |
| 2012 | $16.18B | 1.58% |
| 2011 | $15.93B | 0.73% |
| 2010 | $15.82B | 8.34% |
| 2009 | $14.60B | 8.02% |
| 2008 | $13.52B | 9.89% |
| 2007 | $12.30B | 8.92% |
| 2006 | $11.29B | 12.31% |
| 2005 | $10.05B | 10.65% |
| 2004 | $9.09B | 18.55% |
| 2003 | $7.67B | 19.57% |
| 2002 | $6.41B | 15.47% |
| 2001 | $5.55B | 10.71% |
| 2000 | $5.01B | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $46.59B | 31.28% |
US
|
|
| $25.84B | -27.19% |
US
|
|
| $21.00B | -40.83% |
US
|
|
| - | - |
DE
|
|
| $6.51B | -81.65% |
US
|
